IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: Cancer communications. - 44, 12 (2024) , 1422-1426, ISSN: 2523-3548

Event: Veröffentlichung

(where): Freiburg

(who): Universität

(when): 2024

Creator: Noh, Soojeong
Ryu, Suyeon
Jung, Dokyung
Shin, Sanghee
Jung, Inseong
Kang, Sung‐Min
Kim, Christine Seulki
Choi, Sung‐Jin
Cho, Hanchae
Schwämmle, Melanie
Jeong, Youngtae
Bucher, Felicitas
Choi, Il‐Kyu
Lee, Shin Yup
Im, Sin‐Hyeog
Yea, Kyungmoo
Baek, Moon-Chang

DOI: 10.1002/cac2.12623

URN: urn:nbn:de:bsz:25-freidok-2586202

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Noh, Soojeong
Ryu, Suyeon
Jung, Dokyung
Shin, Sanghee
Jung, Inseong
Kang, Sung‐Min
Kim, Christine Seulki
Choi, Sung‐Jin
Cho, Hanchae
Schwämmle, Melanie
Jeong, Youngtae
Bucher, Felicitas
Choi, Il‐Kyu
Lee, Shin Yup
Im, Sin‐Hyeog
Yea, Kyungmoo
Baek, Moon-Chang
Universität

Time of origin

2024

Other Objects (12)

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Optimized PD-L1 scoring of gastric cancer

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hochschulschrift

PD-L1 Expression in malignen Melanomen der Vulva

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Optimized PD-L1 scoring of gastric cancer

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hochschulschrift

PD-L1 Expression in malignen Melanomen der Vulva

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Optimized PD-L1 scoring of gastric cancer

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hochschulschrift

PD-L1 Expression in malignen Melanomen der Vulva

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells

Object Details

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Optimized PD-L1 scoring of gastric cancer

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

PD-L1 Expression in malignen Melanomen der Vulva

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Optimized PD-L1 scoring of gastric cancer

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

PD-L1 Expression in malignen Melanomen der Vulva

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Optimized PD-L1 scoring of gastric cancer

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

PD-L1 Expression in malignen Melanomen der Vulva

Related objects

Reset password